共 276 条
[1]
McMurray JJ(2014)Angiotensin–neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 993-1004
[2]
Packer M(2020)Efficacy and safety of sacubitril–valsartan in heart failure: a meta-analysis of randomized controlled trials ESC Heart Fail. 7 3841-3850
[3]
Desai AS(2021)Real-world effectiveness and safety of sacubitril/valsartan in heart failure: a systematic review Int J Cardiol 15 164-171
[4]
Gong J(2021)Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis ESC Heart Fail. 8 3547-3556
[5]
Lefkowitz MP(2019)Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril–svalsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction JAMA 322 1085-1095
[6]
Rizkala AR(2020)Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction Future Cardiol 16 227-236
[7]
Zhang H(2008)The reliability of noninvasive cardiac output measurement using the inert gas rebreathing method in patients with advanced heart failure Cardiol J 15 63-70
[8]
Huang T(1997)Non-invasive measurement of cardiac output: whole-body impedance cardiography in simultaneous comparison with thermodilution and direct oxygen Fick methods Intensive Care Med 23 1132-1137
[9]
Shen W(2016)2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 37 2129-2200
[10]
Xu X(2009)Noninvasive determination of cardiac output by the inert-gas-rebreathing method—comparison with cardiovascular magnetic resonance imaging Cardiology 114 247-254